No Detail Found!

A Step towards Personalised Cancer Treatment in Lower Middle-income Countries (LMICS): Molecular Tumour Boards

Author(s)
Agha Muhammad Hammad Khan Department of Radiation Oncology, Sultan Qaboos Comprehensive Cancer Care and Research Centre,Muscat,Oman
Ikram Burney Department of Medical Oncology, Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman
Zeeshan Ansar Department of Pathology, The Aga Khan University Hospital, Karachi, Pakistan
Ahmed Nadeem Abbasi Department of Oncology, The Aga Khan University Hospital, Karachi, Pakistan
Abstract
Tumour boards are meetings where physicians from various disciplines treating cancer patients meet to recommend evidence-based or the best possible treatment plan. These meetings have evolved with time and now, in every part of the world; site-speci c multi-disciplinary tumour boards are established. These meetings are considered pivotal for improving patient outcomes. The advances in molecular and genetic knowledge and technique and their integration in treatment options have paved the way for multiple therapeutic options. However, the adoption of personalised treatment choices is associated with a huge nancial burden, especially in low and middle-income countries (LMICs). A molecular tumour board can help to identify and suggest the most appropriate plan of management.
Publication Details
Page(s) 1070-1072
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 9, Year: 2023

Request the full text from PASTIC

Keywords
Genetics, Challenges, Molecular, Personalised
0

Citations

0

Downloads

217

Views